These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29848111)

  • 1. Protease activated receptor 2 (PAR2) activation causes migraine-like pain behaviors in mice.
    Hassler SN; Ahmad FB; Burgos-Vega CC; Boitano S; Vagner J; Price TJ; Dussor G
    Cephalalgia; 2019 Jan; 39(1):111-122. PubMed ID: 29848111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAR2 activation in the dura causes acute behavioral responses and priming to glyceryl trinitrate in a mouse migraine model.
    Mason BN; Hassler SN; DeFea K; Boitano S; Vagner J; Price TJ; Dussor G
    J Headache Pain; 2023 Apr; 24(1):42. PubMed ID: 37072694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine.
    Kopruszinski CM; Thornton P; Arnold J; Newton P; Lowne D; Navratilova E; Swiokla J; Dodick DW; Dobson C; Gurrell I; Chessell IP; Porreca F
    Cephalalgia; 2020 Dec; 40(14):1535-1550. PubMed ID: 33131305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of meningeal nociceptors mechanosensitivity by peripheral proteinase-activated receptor-2: the role of mast cells.
    Zhang XC; Levy D
    Cephalalgia; 2008 Mar; 28(3):276-84. PubMed ID: 18254896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migraine pain, meningeal inflammation, and mast cells.
    Levy D
    Curr Pain Headache Rep; 2009 Jun; 13(3):237-40. PubMed ID: 19457286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cell degranulation activates a pain pathway underlying migraine headache.
    Levy D; Burstein R; Kainz V; Jakubowski M; Strassman AM
    Pain; 2007 Jul; 130(1-2):166-76. PubMed ID: 17459586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of small peptidomimetic ligands to protease-activated receptor-2 (PAR2) through the use of lipid tethering.
    Boitano S; Hoffman J; Tillu DV; Asiedu MN; Zhang Z; Sherwood CL; Wang Y; Dong X; Price TJ; Vagner J
    PLoS One; 2014; 9(6):e99140. PubMed ID: 24927179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain state.
    Tillu DV; Hassler SN; Burgos-Vega CC; Quinn TL; Sorge RE; Dussor G; Boitano S; Vagner J; Price TJ
    Pain; 2015 May; 156(5):859-867. PubMed ID: 25734998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of mast cells and proteinase-activated receptor 2 in oxaliplatin-induced mechanical allodynia in mice.
    Sakamoto A; Andoh T; Kuraishi Y
    Pharmacol Res; 2016 Mar; 105():84-92. PubMed ID: 26804251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dural Calcitonin Gene-Related Peptide Produces Female-Specific Responses in Rodent Migraine Models.
    Avona A; Burgos-Vega C; Burton MD; Akopian AN; Price TJ; Dussor G
    J Neurosci; 2019 May; 39(22):4323-4331. PubMed ID: 30962278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningeal CGRP-Prolactin Interaction Evokes Female-Specific Migraine Behavior.
    Avona A; Mason BN; Burgos-Vega C; Hovhannisyan AH; Belugin SN; Mecklenburg J; Goffin V; Wajahat N; Price TJ; Akopian AN; Dussor G
    Ann Neurol; 2021 Jun; 89(6):1129-1144. PubMed ID: 33749851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of high homocysteine levels in migraine pain: An experimental study of the excitability of peripheral meningeal afferents in rats with hyperhomocysteinemia.
    Ermakova E; Shaidullova K; Gafurov O; Kabirova A; Nurmieva D; Sitdikova G
    Headache; 2024 May; 64(5):533-546. PubMed ID: 38650105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmon calcitonin ameliorates migraine pain through modulation of CGRP release and dural mast cell degranulation in rats.
    Kilinc E; Dagistan Y; Kukner A; Yilmaz B; Agus S; Soyler G; Tore F
    Clin Exp Pharmacol Physiol; 2018 Jun; 45(6):536-546. PubMed ID: 29344989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain.
    Zhao P; Lieu T; Barlow N; Sostegni S; Haerteis S; Korbmacher C; Liedtke W; Jimenez-Vargas NN; Vanner SJ; Bunnett NW
    J Biol Chem; 2015 May; 290(22):13875-87. PubMed ID: 25878251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of the proinflammatory and pronociceptive actions of canonical and biased agonists of protease-activated receptor-2.
    Lieu T; Savage E; Zhao P; Edgington-Mitchell L; Barlow N; Bron R; Poole DP; McLean P; Lohman RJ; Fairlie DP; Bunnett NW
    Br J Pharmacol; 2016 Sep; 173(18):2752-65. PubMed ID: 27423137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic mechanisms of trigeminal meningeal nociception: Implications for migraine pain.
    Kilinc E; Guerrero-Toro C; Zakharov A; Vitale C; Gubert-Olive M; Koroleva K; Timonina A; Luz LL; Shelukhina I; Giniatullina R; Tore F; Safronov BV; Giniatullin R
    Neuropharmacology; 2017 Apr; 116():160-173. PubMed ID: 28025094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protease-activated receptor-2-specific agonists 2-aminothiazol-4-yl-LIGRL-NH2 and 6-aminonicotinyl-LIGRL-NH2 stimulate multiple signaling pathways to induce physiological responses in vitro and in vivo.
    Flynn AN; Tillu DV; Asiedu MN; Hoffman J; Vagner J; Price TJ; Boitano S
    J Biol Chem; 2011 May; 286(21):19076-88. PubMed ID: 21467041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive dural stimulation in mice: A novel preclinical model of migraine.
    Burgos-Vega CC; Quigley LD; Trevisan Dos Santos G; Yan F; Asiedu M; Jacobs B; Motina M; Safdar N; Yousuf H; Avona A; Price TJ; Dussor G
    Cephalalgia; 2019 Jan; 39(1):123-134. PubMed ID: 29848109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine proteases and protease-activated receptor 2-dependent allodynia: a novel cancer pain pathway.
    Lam DK; Schmidt BL
    Pain; 2010 May; 149(2):263-272. PubMed ID: 20189717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Legumain Induces Oral Cancer Pain by Biased Agonism of Protease-Activated Receptor-2.
    Tu NH; Jensen DD; Anderson BM; Chen E; Jimenez-Vargas NN; Scheff NN; Inoue K; Tran HD; Dolan JC; Meek TA; Hollenberg MD; Liu CZ; Vanner SJ; Janal MN; Bunnett NW; Edgington-Mitchell LE; Schmidt BL
    J Neurosci; 2021 Jan; 41(1):193-210. PubMed ID: 33172978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.